Mitogenic effect of transforming growth factor-β1 on human ito cells in culture: Evidence for mediation by endogenous platelet-derived growth factor
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
We assessed the effect of transforming growth factor-beta 1 on the proliferation of human Ito cells. Ito cells in their myofibroblastlike phenotype were grown from explants of human liver and were characterized with electron microscopy and positive immunostaining for desmin and smooth muscle alpha-actin. Transforming growth factor-beta 1 was mitogenic for human Ito cells whatever the culture conditions, although it was, as previously described, inhibitory of growth for rat Ito cells. The mitogenic effect of transforming growth factor-beta 1 was likely due to induction of autocrine platelet-derived growth factor chain secretion by Ito cells themselves because (a) the mitogenic effect of transforming growth factor-beta 1 was blocked by specific platelet-derived growth factor antibodies, (b) transforming growth factor-beta 1 increased platelet-derived growth factor-A chain messenger RNA expression and platelet-derived growth factor-AA secretion by human Ito cells and (c) human Ito cells expressed the alpha-type platelet-derived growth factor-A receptor messenger RNA. Exogenous platelet-derived growth factor-AA was also mitogenic for human Ito cells, mimicking the effect of transforming growth factor-beta 1. Our data suggest that results obtained with rat Ito cells must be extrapolated with caution to human ones. The mitogenic effect of transforming growth factor-beta 1 on human Ito cells probably has pathophysiological relevance because transforming growth factor-beta 1 has been…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HSC-mediated, fibrogenic signalling pathways include TGFA, keratinocyte growth factor, thrombin, fibroblast growth factor (FGF) and epidermal growth factor which cause proliferation of hepatocytes, cholangiocytes and mesenchymal cells.[121], [122], [123], [124], [125]”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [122]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Fort, P., Marty, L., Piechaczyk, M., Sabrouty, S. E., Dani, C., Jeanteur, P., & Blanchard, J. M. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.5.1431 · Cited by 2,099
TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
Moses, H. L., Yang, E. Y., & Pietenpol, J. A. (1990) · Cell · doi:10.1016/0092-8674(90)90155-8 · Cited by 959
Betsholtz, C., Johnsson, A., Heldin, C.-H., Westermark, B., Lind, P., Urdea, M. S., Eddy, R., Shows, T. B., Philpott, K., Mellor, A. L., et al. (1986) · Nature · doi:10.1038/320695a0 · Cited by 781
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
Transforming Growth Factors β1 and α in Chronic Liver Disease: Effects of Interferon Alfa Therapy
Castilla, A., Prieto, J., & Fausto, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241401 · Cited by 655
Portmann, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80245-6 · Cited by 549
Leof, E. B., Proper, J. A., Goustin, A. S., Shipley, G. D., DiCorleto, P. E., & Moses, H. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2453 · Cited by 529
Pinzani, M., Gesualdo, L., Sabbah, G. M., & Abboud, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114363 · Cited by 478
Research works printed but not linked: 11
- Milani, 1990, Am J Pathol, 137, 59
- Milani, 1989, Am J Pathol, 134, 1175
- Geerts, 1991, Hepatology, 13, 1193
- French, 1988, Am J Pathol, 132, 73
- Malizia, 1990, Hepatology, 12, 950
- Milani, 1991, Am J Pathol, 139, 1221
- , , , . Characterization and main properties of cultured fat-storing cells from human and mouse livers: their characterization with viruses. In: , , eds. Cells of the hepatic sinusoid. Vol II. Rijswijk, The Netherlands: Kupffer Cell Foundation, 1989: 429–433.
- Guigui, 1988, Lab Invest, 59, 831
- McGee, 1972, Lab Invest, 26, 429
- Schmitt-Gräff, 1991, Am J Pathol, 138, 1233
- Casini, 1991, Hepatology, 14, 183a
Cited by
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
Khan, R., & Sheppard, R. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02336.x · Cited by 501
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
Self-citationAydin, M. M., & Akcali, K. C. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17330 · Cited by 381
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
Benyon, R., Iredale, J., Goddard, S., Winwood, P., & Arthur, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608892 · Cited by 353
Lipid Metabolism and Liver Inflammation. I. Hepatic fatty acid uptake: possible role in steatosis
Bradbury, M. W. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00413.2005 · Cited by 339
Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., Müller, E., Rettig, W. J., & Gorrell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290631 · Cited by 336
Hepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Self-citationLee, S.-B., Li, D.-Q., Tan, D. T. H., Meller, D., & Tseng, S. C. G. (2000) · Current Eye Research · doi:10.1076/0271-3683(200004)2041-5ft325 · Cited by 289
Dooley, S., Delvoux, B., Lahme, B., Mangasser-Stephan, K., & Gressner, A. M. (2000) · Hepatology · doi:10.1053/he.2000.6126 · Cited by 230
Myofibroblastic conversion of mesothelial cells
Yang, A. H., Chen, J. Y., & Lin, J. K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00861.x · Cited by 190
Matrix Metalloproteinase 3 Is Present in the Cell Nucleus and Is Involved in Apoptosis
Si-Tayeb, K., Monvoisin, A., Mazzocco, C., Lepreux, S., Decossas, M., Cubel, G., Taras, D., Blanc, J.-F., Robinson, D. R., & Rosenbaum, J. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060005 · Cited by 185
Self-citationInterferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture
Mallat, A., Preaux, A.-M., Blazejewski, S., Rosenbaum, J., Dhumeaux, D., & Mavier, P. (1995) · Hepatology · doi:10.1002/hep.1840210418 · Cited by 180
Self-citationAnkoma-Sey, V., & Friedman, S. L. (1998) · Liver Growth and Repair · doi:10.1007/978-94-011-4932-7_20 · Cited by 173
Gallois, C., Habib, A., Tao, J., Moulin, S., Maclouf, J., Mallat, A., & Lotersztajn, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23183 · Cited by 155
Self-citationYu, C., Wang, F., Jin, C., Huang, X., Miller, D. L., Basilico, C., & McKeehan, W. L. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63522-5 · Cited by 167
“TGF- 1 is considered to be the most potent profibrogenic cytokine in liver fibrosis through activation of HSCs that apparently includes stimulation of an increase in cell number, migratory behavior, and deposition of extracellular matrix components both in vitro and in vivo.(23,34,44,45) We showed here that it is unli…”
BackgroundNeaud, V, Faouzi, S., Guirouilh, J., Le Bail, B., Balabaud, C., Bioulac-Sage, P., & Rosenbaum, J. (1997) · Hepatology · doi:10.1002/hep.510260612 · Cited by 167
Self-citationMatsuyama, S., Iwadate, M., Kondo, M., Saitoh, M., Hanyu, A., Shimizu, K., Aburatani, H., Mishima, H. K., Imamura, T., Miyazono, K., et al. (2003) · PubMed · Cited by 158
15-Deoxy-Δ12,14-prostaglandin J2 Induces Apoptosis of Human Hepatic Myofibroblasts
Li, L., Tao, J., Davaille, J., Féral, C., Mallat, A., Lotersztajn, S., Rieusset, J., & Vidal, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101980200 · Cited by 156
Self-citationMartineau, I., Lacoste, E., & Gagnon, G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.11.013 · Cited by 149
Windmeier, C., & Gressner, A. M. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00314-x · Cited by 146
Préaux, A.-M., Mallat, A., Van Nhieu, J. T., d'Ortho, M.-P., Hembry, R. M., & Mavier, P. (1999) · Hepatology · doi:10.1002/hep.510300432 · Cited by 134
Self-citationHuman hepatic stellate cell isolation and characterization
Shang, L., Hosseini, M., Liu, X., Kisseleva, T., & Brenner, D. A. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1404-4 · Cited by 137
Antiproliferative Properties of Sphingosine 1-Phosphate in Human Hepatic Myofibroblasts
Davaille, J., Gallois, C., Habib, A., Li, L., Mallat, A., Tao, J., Levade, T., & Lotersztajn, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006393200 · Cited by 118
Self-citationTiggelman, A. M. B. C., Boers, W., Linthorst, C., Sala, M., & Chamuleau, R. A. F. M. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(95)80010-7 · Cited by 124
Faouzi, S., Bail, B. L., Neaud, V., Boussarie, L., Saric, J., Bioulac‐Sage, P., Balabaud, C. P., & Rosenbaum, J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80074-9 · Cited by 122
Self-citationMallat, A., Fouassier, L., Préaux, A. M., Gal, C. S., Raufaste, D., Rosenbaum, J., Dhumeaux, D., Jouneaux, C., Mavier, P., & Lotersztajn, S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118052 · Cited by 111
Self-citationHouglum, K., Ramm, G. A., Crawford, D. H., Witztum, J. L., Powell, L. W., & Chojkier, M. (1997) · Hepatology · doi:10.1002/hep.510260311 · Cited by 121
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Mallat, A., Gallois, C., Tao, J., Habib, A., Maclouf, J., Mavier, P., Préaux, A.-M., & Lotersztajn, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27300 · Cited by 101
Self-citationHeparan sulfate proteoglycan expression in normal human liver
Roskams, T., Moshage, H., de Vos, R., Guido, D., Yap, P., & Desmet, V. (1995) · Hepatology · doi:10.1002/hep.1840210410 · Cited by 107
Godichaud, S., Krisa, S., Couronné, B., Dubuisson, L., Mérillon, J.-M., Desmoulière, A., & Rosenbaum, J. (2000) · Hepatology · doi:10.1053/he.2000.5848 · Cited by 105
Self-citationMallat, A., Préaux, A. M., Serradeil-Le Gal, C., Raufaste, D., Gallois, C., Brenner, D. A., Bradham, C., Maclouf, J., Iourgenko, V, Fouassier, L., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119103 · Cited by 105
Self-citationDavaille, J., Li, L., Mallat, A., & Lotersztajn, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202798200 · Cited by 111
Self-citationReichard, O., Glaumann, H., Frydén, A., Norkrans, G., Schvarcz, R., Sönnerborg, A. B., Yun, Z., & Weiland, O. (1995) · Hepatology · doi:10.1002/hep.1840210405 · Cited by 111
Beljaars, L., Weert, B., Geerts, A. E., Meijer, D. K. F., & Poelstra, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00445-3 · Cited by 108
Aoudjehane, L., Pissaia, A., Scatton, O., Podevin, P., Massault, P. P., Chouzenoux, S., Soubrane, O., Calmus, Y., & Conti, F. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.61 · Cited by 107
Reimann, T., Hempel, U., Krautwald, S., Axmann, A., Scheibe, R., Seidel, D., & Wenzel, K.-W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00024-0 · Cited by 101
Sempoux, C. L., Horsmans, Y., Geubel, A., Fraikin, J., BEERS, B. E. V., Gigot, J. F., Lerut, J. P., & Rahier, J. (1997) · Hepatology · doi:10.1002/hep.510260117 · Cited by 98
Growth factor and procollagen type I gene expression in human liver disease
Malizia, G., Brunt, E. M., Peters, M. G., Rizzo, A., Broekelmann, T. J., & McDonald, J. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90019-5 · Cited by 89
Ingram, J. L., Rice, A. B., Geisenhoffer, K., Madtes, D. K., & Bonner, J. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1492fje · Cited by 89
Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2
Preaux, A.-M., D’Ortho, M.-P., Bralet, M.-P., Laperche, Y., & Mavier, P. (2002) · Hepatology · doi:10.1053/jhep.2002.35279 · Cited by 82
Self-citationMonvoisin, A., Bisson, C., Si‐Tayeb, K., Balabaud, C. P., Desmoulière, A., & Rosenbaum, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1595 · Cited by 85
Self-citationBenten, D., Kumaran, V., Joseph, B., Schattenberg, J., Popov, Y., Schuppan, D., & Gupta, S. (2005) · Hepatology · doi:10.1002/hep.20889 · Cited by 81
Hepatic stellate cells’ involvement in progenitor-mediated liver regeneration
Pintilie, D. G., Shupe, T. D., Oh, S.-H., Salganik, S. V., Darwiche, H., & Petersen, B. E. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.88 · Cited by 76
Rosenbaum, J., Blazejewski, S., Préaux, A.-M., Mallat, A., Dhumeaux, D., & Mavier, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90767-x · Cited by 78
Self-citationLorena, D., Darby, I. A., Reinhardt, D. P., Sapin, V., Rosenbaum, J., & Desmoulière, A. (2003) · Laboratory Investigation · doi:10.1038/labinvest.3700023 · Cited by 78
Self-citationOhishi, T., Saito, H., Tsusaka, K., Toda, K., Inagaki, H., Hamada, Y., Kumagai, N., Atsukawa, K., & Ishii, H. (2001) · Hepatology Research · doi:10.1016/s1386-6346(01)00102-4 · Cited by 77
Transforming growth factor β and cancer
Nørgaard, P. H., Hougaard, S., Poulsen, H. S., & Spang‐Thomsen, M. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90038-1 · Cited by 77
Rupérez, M. R. M. (2006) · Editorial Trotta eBooks · Cited by 75
Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells
Inoue, T., & Jackson, E. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00418-5 · Cited by 74
Préaux, A.-M., Mallat, A., Rosenbaum, J., Zafrani, É. S., & Mavier, P. (1997) · Hepatology · doi:10.1002/hep.510260210 · Cited by 72
Self-citationBiological Effects of C-type Natriuretic Peptide in Human Myofibroblastic Hepatic Stellate Cells
Tao, J., Mallat, A., Gallois, C., Pavoine, C., Lotersztajn, S., Belmadani, S., Méry, P.-F., & Nhieu, J. T.-V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23761 · Cited by 60
Self-citationMarra, F., Choudhury, G. G., Pinzani, M., & Abboud, H. E. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90236-4 · Cited by 71
In vivo and in vitro Interactions between Human Colon Carcinoma Cells and Hepatic Stellate Cells
Shimizu, S., Yamada, N., Sawada, T., Ikeda, K., Kawada, N., Seki, S., Kaneda, K., & Hirakawa, K. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00916.x · Cited by 68
Monvoisin, A., Neaud, V., de Lédinghen, V., Dubuisson, L., Balabaud, C. P., Bioulac‐Sage, P., Desmoulière, A., & Rosenbaum, J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80113-5 · Cited by 67
Self-citationHuman liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts
Lepreux, S., & Desmoulière, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00173 · Cited by 58
Heparan Sulfate Proteoglycan Expression in Chronic Cholestatic Human Liver Diseases
Roskams, T., Rosenbaum, J., Vos, R. D., David, G., & Desmet, V. (1996) · Hepatology · doi:10.1002/hep.510240310 · Cited by 66
Self-citationOsteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.
Blazejewski, S., Bail, B. L., Boussarie, L., Blanc, J., Malaval, L., Okubo, K., Saric, J., Bioulac‐Sage, P., & Rosenbaum, J. (1997) · Europe PMC (PubMed Central) · Cited by 66
Self-citationNeaud, V., Hisaka, T., Monvoisin, A., Bedin, C., Balabaud, C. P., Foster, D. C., Desmoulière, A., Kisiel, W., & Rosenbaum, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006101200 · Cited by 64
Self-citationClouzeau‐Girard, H., Guyot, C., Combe, C., Moronvalle-Halley, V., Housset, C., Lamireau, T., Rosenbaum, J., & Desmoulière, A. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700386 · Cited by 61
Self-citationFibrosis Accelerates the Development of Enzyme–Altered Lesions in the Rat Liver
Sakaida, I., Hironaka, K., Uchida, K., Suzuki, C., Kayano, K., & Okita, K. (1998) · Hepatology · doi:10.1002/hep.510280512 · Cited by 58
Blazejewski, S., Préaux, A.-M., Mallat, A., Brochériou, I., Mavier, P., Dhumeaux, D., Hartmann, D. J., Schuppan, D., & Rosenbaum, J. (1995) · Hepatology · doi:10.1002/hep.1840220315 · Cited by 57
Self-citationCellular Targeting of the Apoptosis-Inducing Compound Gliotoxin to Fibrotic Rat Livers
Hagens, W. I., Beljaars, L., Mann, D. A., Wright, M. C., Julien, B., Lotersztajn, S., Reker‐Smit, C., & Poelstra, K. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132290 · Cited by 54
Transforming growth factor ?2, but not ?1 and ?3, is critical for early rat lung branching
Liu, J., Tseu, I., Wang, J., Tanswell, K. A., & Post, M. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200004)217:4<343::aid-dvdy2>3.0.co;2-f · Cited by 54
Tangkijvanich, P., Santiskulvong, C., Melton, A. C., Rozengurt, E., & Yee, H. F. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10112 · Cited by 53
Österreicher, C., Datz, C., Stickel, F., Hellerbrand, C., Penz, M., HOFER, H., Wrba, F., Penner, E., Schuppan, D., & Ferenci, P. (2005) · Cytokine · doi:10.1016/j.cyto.2005.03.005 · Cited by 52
Demirci, G., Nashan, B., & Pichlmayr, R. (1996) · Transplantation · doi:10.1097/00007890-199612270-00016 · Cited by 51
Fu, Y., Zheng, S., Lu, S. C.-L., & Chen, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.040634 · Cited by 50
Fibbi, G., Pucci, M., Grappone, C., Pellegrini, G., Salzano, R., Casini, A., Milani, S., & Del Rosso, M. (1999) · Hepatology · doi:10.1002/hep.510290343 · Cited by 49
Lamireau, T., Bail, B. L., Boussarie, L., Fabrè, M., Vergnes, P., Bernard, O., Gautier, F., Bioulac‐Sage, P., & Rosenbaum, J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80221-9 · Cited by 49
Self-citationNørgaard, P. H., Spang‐Thomsen, M., & Poulsen, H. S. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.201 · Cited by 47
Suflețel, R. T., Melincovici, C. S., Gheban, B., Zaharie, T., & Mihu, C. M. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.3.01 · Cited by 46
Abhilash, P. A., Harikrishnan, R., & Indira, M. (2011) · Free Radical Research · doi:10.3109/10715762.2011.647691 · Cited by 45
Neaud, V., Gillibert-Duplantier, J., Mazzocco, C., Kisiel, W., & Rosenbaum, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306679200 · Cited by 45
Self-citationStrain, A. J., Wallace, L. M., Joplin, R., Daikuhara, Y., Ishii, T., Kelly, D. A., & Neuberger, J. (1995) · Europe PMC (PubMed Central) · Cited by 41
Mangasser-Stephan, K., Gartung, C., Lahme, B., & Gressner, A. M. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021002105.x · Cited by 39
Targeted delivery of drugs for liver fibrosis
Li, F., & Wang, J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902936834 · Cited by 38
Yeh, T., Ho, Y., Huang, S.-F., Yeh, J.-N., Jan, Y.-Y., & Chen, M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.019 · Cited by 38
Colman‐Lerner, A., Salamone, D., Chiappe, M. E., & Barañao, J. L. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041640220 · Cited by 38
Tangkijvanich, P., Melton, A. C., Chitapanarux, T., Han, J., & Yee, H. F. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5657 · Cited by 37
Lee, M., Miau, L.-H., Chen, C., Chiou, L., Huang, G., Yang, P., & Sheu, J. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256328 · Cited by 35
Eghbali-Fatourechi, G., Sieck, G. C., Prakash, Y. S., Maercklein, P. B., Gores, G. J., & Fitzpatrick, L. A. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612529 · Cited by 34
Couchie, D., Lafdil, F., Martin‐Garcia, N., Laperche, Y., Zafrani, É. S., & Mavier, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.004 · Cited by 33
Self-citationMallat, A., Préaux, A.-M., Blazejewski, S., Dhumeaux, D., Rosenbaum, J., & Mavier, P. (1994) · Hepatology · doi:10.1002/hep.1840200631 · Cited by 33
Self-citationYata, Y., Takahara, T., Furui, K., Zhang, L. P., & Watanabe, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80100-7 · Cited by 32
Peterson, T. C., Isbrucker, R. A., & Hooper, M. L. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90061-2 · Cited by 32
Brunati, A. M., Tibaldi, E. V., Carraro, A., Gringeri, E., D’Amico, F., Toninello, A., Massimino, M. L., Pagano, M. A., Nalesso, G., & Cillo, U. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.11.008 · Cited by 31
Godichaud, S., Si‐Tayeb, K., Augè, N., Desmoulière, A., Balabaud, C. P., Payrastre, B., Nègre‐Salvayre, A., & Rosenbaum, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.11.001 · Cited by 29
Self-citationPentoxifylline prevents pig serum‐induced rat liver fibrosis by inhibiting interleukin‐6 production
Toda, K., Kumagai, N., Kaneko, F., Tsunematsu, S., Tsuchimoto, K., Saito, H., & Hibi∥, T. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05749.x · Cited by 28
Rho and p38 MAP Kinase Signaling Pathways Mediate LPA-Stimulated Hepatic Myofibroblast Migration
Tangkijvanich, P., Melton, A. C., Santiskulvong, C., & Yee, H. F. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256455 · Cited by 27
Fibbi, G., Pucci, M., D’Alessio, S., Grappone, C., Pellegrini, G., Salzano, R., Casini, A., Milani, S., & Rosso, M. D. (2001) · Growth Factors · doi:10.3109/08977190109001078 · Cited by 26
Wang, L. T., Zhang, B., & Chen, J.-J. (2000) · World Journal of Gastroenterology · doi:10.3748/wjg.v6.i6.877 · Cited by 26
Scharf, J., Schmidt-Sandte, W., Pahernik, S. A., Koebe, H. G., & Hartmann, H. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80201-0 · Cited by 26
Additive effect of alpha-tocopherol and ascorbic acid in combating ethanol-induced hepatic fibrosis
Prathibha, P., Rejitha, S., Harikrishnan, R., Das, S. S., Abhilash, P. A., & Indira, M. (2013) · Redox Report · doi:10.1179/1351000212y.0000000038 · Cited by 23
Weerda, T. I. G. H. G. (1998) · Acta Oto-Laryngologica · doi:10.1080/00016489850183412 · Cited by 21
Tuleta, I., & Frangogiannis, N. G. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00403.2025 · Cited by 20
Co-administration of cyclosporine A alleviates thioacetamide-induced liver injury
Fan, S. M., & Weng, C.-F. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i10.1411 · Cited by 19
Metadata
- Authors
- Win, K. M., Charlotte, F., Mallat, A., Cherqui, D., Martin, N., Mavier, P., Preaux, A.-M., Dhumeau, D., & Rosenbaum, J.
- Affiliations
- Inserm (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Corresponding author
- Rosenbaum, Jean
- Venue
- Hepatology
- Published
- 1993-07
- Volume
- 18
- Issue
- 1
- Pages
- 137-145
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4298095757
- Cited by
- 102
- References
- 49
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 2 · 2020: 2 · 2018: 3 · 2017: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 8097 d)
- Locations
- Hepatology (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- TGF-β1, hepatic stellate cells, mitogen response, PDGF-AA, platelet-derived growth factor receptor, cell proliferation, liver fibrosis, myofibroblast phenotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.